US dialysis facility closures from 2018 to 2023 have raised concerns about access to vital care, especially in rural communities. Despite an increase in adults diagnosed with end-stage renal disease, there has been a decrease in facility openings. Additionally, a study found that clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia. The KidneyIntelX test has shown promising results in improving hypertension in patients with diabetic kidney disease. Other topics of interest include hydralazine-induced autoimmune conditions, outcomes of chlorthalidone vs. hydrochlorothiazide among veterans, and the need to address social disparities in kidney disease care.
Source link
Top nephrology meeting news in 2024
